Transplant-Associated Thrombotic Microangiopathy
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| yartemlea | OMEROS CORP (OMER) |
Frequently asked questions
How many drugs are in development for Transplant-Associated Thrombotic Microangiopathy?
BioSniper tracks 1 drug in development for Transplant-Associated Thrombotic Microangiopathy across 1 company.
How many clinical trials target Transplant-Associated Thrombotic Microangiopathy?
There are 1 clinical trial targeting Transplant-Associated Thrombotic Microangiopathy tracked by BioSniper.
Deep-dive into Transplant-Associated Thrombotic Microangiopathy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis